{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:45:01Z","timestamp":1764783901451},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bpgastro.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.bpg.2016.09.001","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T17:46:32Z","timestamp":1473788792000},"page":"879-891","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cost effectiveness of surveillance for GI cancers"],"prefix":"10.1016","volume":"30","author":[{"given":"Amir-Houshang","family":"Omidvari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinier G.S.","family":"Meester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Lansdorp-Vogelaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2016.09.001_bib1","series-title":"GI epidemiology: diseases and clinical methodology","author":"Talley","year":"2013"},{"issue":"5","key":"10.1016\/j.bpg.2016.09.001_bib2","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/j.gastro.2012.08.002","article-title":"Burden of gastrointestinal disease in the United States: 2012 update","volume":"143","author":"Peery","year":"2012","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.bpg.2016.09.001_bib3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/2050640614554154","article-title":"Survey of digestive health across Europe: final report. Part 1: the burden of gastrointestinal diseases and the organisation and delivery of gastroenterology services across Europe","volume":"2","author":"Farthing","year":"2014","journal-title":"United Eur Gastroenterol J"},{"issue":"8","key":"10.1016\/j.bpg.2016.09.001_bib4","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ajg.2014.156","article-title":"Surveillance of Barrett's esophagus and mortality from esophageal adenocarcinoma: a population-based cohort study","volume":"109","author":"Verbeek","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"15","key":"10.1016\/j.bpg.2016.09.001_bib5","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","article-title":"Incidence of adenocarcinoma among patients with Barrett's esophagus","volume":"365","author":"Hvid-Jensen","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"237","key":"10.1016\/j.bpg.2016.09.001_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/00855910310001430","article-title":"Cost-effectiveness of colorectal cancer surveillance in ulcerative colitis","author":"Inadomi","year":"2003","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"3","key":"10.1016\/j.bpg.2016.09.001_bib7","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1053\/j.gastro.2011.01.030","article-title":"American Gastroenterological Association medical position statement on the management of Barrett's esophagus","volume":"140","author":"American Gastroenterological Association","year":"2011","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bpg.2016.09.001_bib8","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/j.gastro.2009.12.037","article-title":"AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease","volume":"138","author":"Farraye","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2016.09.001_bib9","series-title":"Colonoscopic surveillance for prevention of colorectal cancer in people with ulcerative colitis","author":"National Institute for Health and Clinical Excellence","year":"2011"},{"issue":"4","key":"10.1016\/j.bpg.2016.09.001_bib10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1053\/j.gastro.2015.01.015","article-title":"American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts","volume":"148","author":"Vege","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2016.09.001_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/epirev\/mxr005","article-title":"Reconsidering the criteria for evaluating proposed screening programs: reflections from 4 current and former members of the U.S. Preventive services task force","volume":"33","author":"Harris","year":"2011","journal-title":"Epidemiol Rev"},{"issue":"6","key":"10.1016\/j.bpg.2016.09.001_bib12","first-page":"535","article-title":"First principles of cost-effectiveness analysis in health","volume":"94","author":"Shepard","year":"1979","journal-title":"Public Health Rep"},{"issue":"9","key":"10.1016\/j.bpg.2016.09.001_bib13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1525-1497.1997.07107.x","article-title":"Assessing the effectiveness of health interventions for cost-effectiveness analysis. Panel on cost-effectiveness in health and medicine","volume":"12","author":"Mandelblatt","year":"1997","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.bpg.2016.09.001_bib14","series-title":"Cost-effectiveness in health and medicine","author":"Gold","year":"1996"},{"issue":"4","key":"10.1016\/j.bpg.2016.09.001_bib15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bpg.2010.04.004","article-title":"Cost-effectiveness of colorectal cancer screening - an overview","volume":"24","author":"Lansdorp-Vogelaar","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"9","key":"10.1016\/j.bpg.2016.09.001_bib16","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1038\/ajg.2009.264","article-title":"Cost effectiveness of ulcerative colitis surveillance in the setting of 5-aminosalicylates","volume":"104","author":"Rubenstein","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.bpg.2016.09.001_bib17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.gie.2013.10.026","article-title":"Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis","volume":"79","author":"Konijeti","year":"2014","journal-title":"Gastrointest Endosc"},{"issue":"11","key":"10.1016\/j.bpg.2016.09.001_bib18","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1097\/MIB.0000000000000181","article-title":"Colorectal cancer surveillance in patients with inflammatory bowel disease and primary sclerosing cholangitis: an economic evaluation","volume":"20","author":"Negron","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.bpg.2016.09.001_bib19","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.gie.2014.02.1031","article-title":"A\u00a0risk-profiling approach for surveillance of inflammatory bowel disease-colorectal carcinoma is more cost-effective: a comparative cost-effectiveness analysis between international guidelines","volume":"80","author":"Lutgens","year":"2014","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"10.1016\/j.bpg.2016.09.001_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2036.2002.01146.x","article-title":"Medical decision analysis of endoscopic surveillance of Barrett's oesophagus to prevent oesophageal adenocarcinoma","volume":"16","author":"Sonnenberg","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.bpg.2016.09.001_bib21","first-page":"588","article-title":"Surveillance of Barrett's oesophagus: is it worthwhile?","volume":"44","author":"Somerville","year":"2008","journal-title":"Eur J Cancer Oxford, Engl 1990"},{"issue":"6","key":"10.1016\/j.bpg.2016.09.001_bib22","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1136\/gutjnl-2014-307197","article-title":"Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis","volume":"64","author":"Kastelein","year":"2015","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.bpg.2016.09.001_bib23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.gie.2013.07.046","article-title":"Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett's esophagus","volume":"79","author":"Gordon","year":"2014","journal-title":"Gastrointest Endosc"},{"issue":"7","key":"10.1016\/j.bpg.2016.09.001_bib24","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1053\/j.gastro.2009.02.062","article-title":"A\u00a0cost-utility analysis of ablative therapy for Barrett's esophagus","volume":"136","author":"Inadomi","year":"2009","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bpg.2016.09.001_bib25","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-0029-1214612","article-title":"An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus","volume":"41","author":"Das","year":"2009","journal-title":"Endoscopy"},{"issue":"12","key":"10.1016\/j.bpg.2016.09.001_bib26","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1136\/gut.2003.033837","article-title":"What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis","volume":"53","author":"Shaheen","year":"2004","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.bpg.2016.09.001_bib27","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0016-5085(03)00393-7","article-title":"Medical decision analysis of chemoprevention against esophageal adenocarcinoma","volume":"124","author":"Sonnenberg","year":"2003","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.bpg.2016.09.001_bib28","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1053\/j.gastro.2010.03.004","article-title":"Surveillance colonoscopy is cost-effective for patients with adenomas who are at high risk of colorectal cancer","volume":"138","author":"Saini","year":"2010","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bpg.2016.09.001_bib29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1365-2036.2001.00969.x","article-title":"Surveillance colonoscopy or chemoprevention with COX-2 inhibitors in average-risk post-polypectomy patients: a decision analysis","volume":"15","author":"Arguedas","year":"2001","journal-title":"Alimentary Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.bpg.2016.09.001_bib30","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1017\/S026646230909028X","article-title":"Can calcium chemoprevention of adenoma recurrence substitute or serve as an adjunct for colonoscopic surveillance?","volume":"25","author":"Shaukat","year":"2009","journal-title":"Int J Technol Assess Health Care"},{"issue":"5","key":"10.1016\/j.bpg.2016.09.001_bib31","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/DCR.0b013e31819f244e","article-title":"Cost-effectiveness of early one-year colonoscopy surveillance after polypectomy","volume":"52","author":"Hassan","year":"2009","journal-title":"Dis Colon Rectum"},{"issue":"5\u20136","key":"10.1016\/j.bpg.2016.09.001_bib32","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1159\/000108969","article-title":"A\u00a0clinical and economic evaluation of endoscopic ultrasound for patients at risk for familial pancreatic adenocarcinoma","volume":"7","author":"Rubenstein","year":"2007","journal-title":"Pancreatol Off J Int Assoc Pancreatol (IAP)"},{"issue":"1","key":"10.1016\/j.bpg.2016.09.001_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mge.2003.28","article-title":"Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds","volume":"57","author":"Rulyak","year":"2003","journal-title":"Gastrointest Endosc"},{"issue":"7","key":"10.1016\/j.bpg.2016.09.001_bib34","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1245\/s10434-013-2889-6","article-title":"Frequency and intensity of postoperative surveillance after curative treatment of pancreatic cancer: a cost-effectiveness analysis","volume":"20","author":"Tzeng","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.bpg.2016.09.001_bib35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/hel.12150","article-title":"Cost-utility analysis of endoscopic surveillance of patients with gastric premalignant conditions","volume":"19","author":"Areia","year":"2014","journal-title":"Helicobacter"},{"issue":"3","key":"10.1016\/j.bpg.2016.09.001_bib36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1523-5378.2010.00752.x","article-title":"Cost-effectiveness of endoscopic surveillance for gastric intestinal metaplasia","volume":"15","author":"Hassan","year":"2010","journal-title":"Helicobacter"},{"issue":"11","key":"10.1016\/j.bpg.2016.09.001_bib37","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ecco-jcc\/jjv141","article-title":"European evidence-based consensus: inflammatory bowel disease and malignancies","volume":"9","author":"Annese","year":"2015","journal-title":"J\u00a0Crohns Colitis"},{"issue":"1","key":"10.1016\/j.bpg.2016.09.001_bib38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-0031-1291491","volume":"44","author":"Dinis-Ribeiro","year":"2012","journal-title":"Endoscopy"},{"issue":"1","key":"10.1016\/j.bpg.2016.09.001_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gutjnl-2013-305372","article-title":"British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus","volume":"63","author":"Fitzgerald","year":"2014","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.bpg.2016.09.001_bib40","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1055\/s-0033-1344548","article-title":"Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) guideline","volume":"45","author":"Hassan","year":"2013","journal-title":"Endoscopy"},{"issue":"3","key":"10.1016\/j.bpg.2016.09.001_bib41","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.MIB.0000160811.76729.d5","article-title":"Crohn's, Colitis Foundation of America Colon Cancer in IBDSG. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease","volume":"11","author":"Itzkowitz","year":"2005","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.bpg.2016.09.001_bib42","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.2010.224154","article-title":"Guidelines for the management of inflammatory bowel disease in adults","volume":"60","author":"Mowat","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2016.09.001_bib43","series-title":"Barrett's oesophagus: ablative therapy for the treatment of Barrett's oesophagus","author":"National Institute for Health and Clinical Excellence","year":"2010"},{"issue":"4","key":"10.1016\/j.bpg.2016.09.001_bib44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2471\/BLT.07.050112","article-title":"Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years","volume":"86","author":"Andermann","year":"2008","journal-title":"Bull World Health Organ"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691816300555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691816300555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T13:25:59Z","timestamp":1536413159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691816300555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1521691816300555"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2016.09.001","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost effectiveness of surveillance for GI cancers","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2016.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}